IN8bio, Inc (NASDAQ: INAB): Our Biotech Focus Stock
IN8bio, Inc (NASDAQ: INAB) just released very enticing positive data from their phase 1 investigator-sponsored trial of INB-100 in Leukemia patients.
Stay updated with breaking news from Galecto Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
IN8bio, Inc (NASDAQ: INAB) just released very enticing positive data from their phase 1 investigator-sponsored trial of INB-100 in Leukemia patients.
On Friday, Petros Pharmaceuticals (NASDAQ: PTPI) stock witnessed a significant uptick in value, despite the absence of any company updates regarding its men's health pharmaceutical products. There’s no evidence of any press release or filed reports with the U.S. Securities or Exchange Commission to explain the rise in value. To Find out the inside Scoop
Nuburu, Inc. (NYSEAMERICAN: BURU) develops and manufactures industrial blue lasers for high brightness and power. Their lasers enhance the speed and quality of laser welding and additive manufacturing of vital industrial metals like copper, gold, and aluminum. Compared to traditional methods, NUBURU's industrial blue lasers can produce minimal to defect-free welds up to eight times
A new peer-reviewed medical journal article demonstrates a functional cure for COVID-19, influenza, and RSV. ProLectin-M also eliminates symptoms.